RxDoctor Payments Data

Jenna Carter, PA

Physician Assistant · South Lyon, MINPI 1306503602

Payments from drug & device makers

$1,872in general payments, 2019–2025

Across 106 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$429
  • Lilly USA, LLC$236
  • Boehringer Ingelheim$232
  • AbbVie$209
  • Bayer$203
  • Biohaven Pharmaceutical Holding Company Ltd.$97
  • plus $466 from 14 others

What the payments were for

  • Food & beverage$1,872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,872 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$51,318
Medicare patients
193
Services billed
829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin19$18,290
EliquisApixaban11$8,343
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$7,426
Bupropion XlBupropion Hcl15$2,489
Atorvastatin Calcium62$648
Metoprolol Succinate31$601
Losartan Potassium52$558
Rosuvastatin Calcium34$492
Levothyroxine Sodium35$381
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$360
Duloxetine Hcl18$331
Amlodipine Besylate52$318
Albuterol Sulfate HfaAlbuterol Sulfate12$302
Omeprazole23$293
Gabapentin16$262

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$232$18,29019 claims
PfizerEliquis$71$8,34311 claims
GSKTrelegy Ellipta$55$7,42613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in South Lyon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →